Evidence map›Paper›PMID 35163038›Full record

ReviewInternational journal of molecular sciences2022

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.

Piero Portincasa, Leonilde Bonfrate, Mirco Vacca, Maria De Angelis, Ilaria Farella, Elisa Lanza, Mohamad Khalil, David Q-H Wang, Markus Sperandio, Agostino Di Ciaula

4 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 525 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
525citing papers in PubMed, 4 pooled it
68.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05447351 unknown statusnot on this mapstarted 2023, after this paper: background citation

Effects of Personalized Dietary and Lifestyle Treatments on the Reduction of Cardiovascular and Metabolic Risk in Overweight and Obese Patients

Typeobservational_patient_registrySponsorUniversity of BariRan2023 to 2025Enrolled200ConditionsOverweight and Obesity, Cardiovascular Diseases, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease
NCT05451992 nacompletednot on this map

Beneficial Effect of Mediterranean (MD) Components on the Structure and Functions of Gut Microbiome and Metabolome in Subjects With Low Adherence to MD

TypeinterventionalSponsorUniversity of BariRan2021 to 2021Enrolled40ConditionsMicrobiota, Overweight and Obesity, Metabolic ComplicationArmsPlacebo, SuperFood
NCT06408610 nacompletednot on this mapstarted 2024, after this paper: background citation

Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and Glucagon Like Peptide Hormone in Irritable Bowel Syndrome

TypeinterventionalSponsorCairo UniversityRan2024 to 2025Enrolled66ConditionsIrritable Bowel Syndrome, Obesity, DysbiosisArmsmoderate intensity continuous training
NCT07035704 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

De-Risking Metabolic, Environmental and Behavioral Determinants of Obesity in Children, Adolescents and Young Adults

TypeinterventionalSponsorpiero portincasaRan2025 to 2027Enrolled200ConditionsOverweight (BMI &gt, 25)ArmsMeD enriched with mushrooms, MeD enriched the Lebanese herbal mixture Za'atar, MeD Diet + semaglutinine or compatible treatment+ Za'atar or Mushroom (to be defined)
3 · Its place in the literature

Who cites it

525 citing papers in PubMed, 4 syntheses or guidelines pooled it, 849 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Short-chain fatty acids in the treatment of ulcerative colitis. Systematic review and meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. ProbioticGut microbes · 2026
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

465 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Piero PortincasaClinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0001-5359-1471
Leonilde BonfrateClinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.
Mirco VaccaDepartment of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Via Amendola 165/a, 70126 Bari, Italy.ORCID 0000-0003-0813-169X
Maria De AngelisDepartment of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Via Amendola 165/a, 70126 Bari, Italy.ORCID 0000-0002-2010-884X
Ilaria FarellaClinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.
Elisa LanzaClinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.
Mohamad KhalilClinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.
David Q-H WangDepartment of Medicine and Genetics, Division of Gastroenterology and Liver Diseases, Marion Bessin Liver Research Center, Einstein-Mount Sinai Diabetes Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Markus SperandioBiomedical Center (BMC), Institute for Cardiovascular Physiology and Pathophysiology, Walter Brendel Center for Experimental Medicine (WBex), Faculty of Medicine, Ludwig-Maximilians-Universität Munich, 82152 Planegg-Martinsried, Germany.ORCID 0000-0002-7689-3613
Agostino Di CiaulaClinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-5476-7376
University of Bari Aldo Moro · ITAlbert Einstein College of Medicine · USLudwig-Maximilians-Universität München · DE

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
GPR30 and hepatic cholesterol metabolismR01DK126369 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PESSIN, JEFFREY E. · 2020 to 2023
$1.9M
NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK126369
6 · The paper itself

Abstract

Gut microbiota encompasses a wide variety of commensal microorganisms consisting of trillions of bacteria, fungi, and viruses. This microbial population coexists in symbiosis with the host, and related metabolites have profound effects on human health. In this respect, gut microbiota plays a pivotal role in the regulation of metabolic, endocrine, and immune functions. Bacterial metabolites include the short chain fatty acids (SCFAs) acetate (C2), propionate (C3), and butyrate (C4), which are the most abundant SCFAs in the human body and the most abundant anions in the colon. SCFAs are made from fermentation of dietary fiber and resistant starch in the gut. They modulate several metabolic pathways and are involved in obesity, insulin resistance, and type 2 diabetes. Thus, diet might influence gut microbiota composition and activity, SCFAs production, and metabolic effects. In this narrative review, we discuss the relevant research focusing on the relationship between gut microbiota, SCFAs, and glucose metabolism.

Indexed as

Gastrointestinal MicrobiomeHomeostasisAnimalsBacteriaFatty Acids, VolatileGlucoseHumansFatty Acids, VolatileGlucosebacteriadietfiberglucose homeostasisintestinemetabolome

Identifiers

PMID35163038
PMCPMC8835596
OpenAlexW4206620445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.